These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3311372)

  • 1. [Ketanserin in ischemic disease of the lower extremities. Results of a double-blind cross-over study].
    Broulíková A; Linhart J
    Cas Lek Cesk; 1987 Sep; 126(35-36):1094-6. PubMed ID: 3311372
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ketanserin in the treatment of ischemic disease of the lower extremities].
    Gerová Z; Brimichová E; Dzúrik R
    Cas Lek Cesk; 1985 Jul; 124(30):938-41. PubMed ID: 3161617
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effectiveness of a Ginkgobiloba preparation in arterial ischemic diseases of the leg. Controlled double-blind cross-over study].
    Salz H
    Ther Ggw; 1980 Nov; 119(11):1345-56. PubMed ID: 7466686
    [No Abstract]   [Full Text] [Related]  

  • 4. The effectiveness of ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled study.
    van de Wal HJ; Wijn PF; van Lier HJ; Skotnicki SH
    Int Angiol; 1987; 6(3):313-22. PubMed ID: 3329207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double blind clinical experiences with L.S. 121 (praxilene) in patients with chronic ischemic peripheral syndromes].
    Bianchi G
    Minerva Chir; 1974 Aug; 29(15-16):885-90. PubMed ID: 4607675
    [No Abstract]   [Full Text] [Related]  

  • 6. Healing effect of ketanserin on chronic leg ulcers in patients with diabetes.
    Quatresooz P; Kharfi M; Paquet P; Vroome V; Cauwenbergh G; Piérard GE
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):277-81. PubMed ID: 16503887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin and the cardiovascular response to intubation: a preliminary report.
    Murray WB; Daniel CH
    Eur J Anaesthesiol; 1987 Nov; 4(6):401-9. PubMed ID: 3328682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of systemic scleroderma with ketanserin. Randomized, double-blind 6-months study of 27 cases].
    Cadranel J; Blétry O; Guillevin L; Lacombe C; Fraitag B; Duloroy J; Mouthon JM; Godeau P
    Ann Med Interne (Paris); 1986; 137(3):260-3. PubMed ID: 3532900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra arterial ketanserin in peripheral vascular disease.
    Boas RA
    Angiology; 1986 Apr; 37(4):267-71. PubMed ID: 2940946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol#0207-546: a phase I/II, double-blind, randomized, placebo-controlled study to assess the safety and efficacy of AMG0001 to improve perfusion in critical leg ischemia.
    Powell RJ
    Hum Gene Ther; 2003 Feb; 14(3):302-6. PubMed ID: 12653095
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical significance of serotonin antagonists].
    Regenthal R; Voigt H
    Z Gesamte Inn Med; 1989 Sep; 44(17):504-8. PubMed ID: 2686226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of peripheral arterial disease with prostacyclin. I. Effect of prostacyclin on the healing of ischemic ulcers of the lower extremities].
    Nizankowski R
    Kardiol Pol; 1986; 29(3):209-17. PubMed ID: 3534429
    [No Abstract]   [Full Text] [Related]  

  • 14. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study].
    Testart J; Guidicelli H; Glanddier G; Mosnier M
    Ann Cardiol Angeiol (Paris); 1994 Nov; 43(9):542-7. PubMed ID: 7864561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of retinal vascular disorders by modification of blood viscosity--a randomized double-blind study].
    Brunner R; Heinen A; Konen W; Hossmann V; Gaethgens P
    Fortschr Ophthalmol; 1984; 81(5):440-3. PubMed ID: 6389281
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic effect of ticlopidine for ischemic leg ulcers.
    Katsumura T
    Agents Actions Suppl; 1984; 15():167-72. PubMed ID: 6385645
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
    Utratová J; Mayer J; Elbl L; Vorlícek J; Prásek J
    Vnitr Lek; 1993 Jun; 39(6):575-80. PubMed ID: 8212613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon induced severe digital ischaemia in chronic myeloid leukaemia--successful treatment using ketanserin.
    Sachithanandan A; Cuthbert RJ; Barros d'Sa AA
    Eur J Vasc Endovasc Surg; 2001 Nov; 22(5):474-6. PubMed ID: 11735190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.